Inventor
MURRAY PETER JOHN
GB39 patents
⚠️ This page may combine multiple inventors who share the name “MURRAY PETER JOHN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
RESPIVERT LTD
13 patentsUS8975285B2Mar 10, 2015
P38 MAP kinase inhibitors
RESPIVERT LTD26 citations92
US9249125B2Feb 2, 2016
Pyrazole derivatives as p38 MAP inhibitors
RESPIVERT LTD30 citations91
US9242960B2Jan 26, 2016
P38MAP kinase inhibitors
RESPIVERT LTD6 citations83
US9701670B2Jul 11, 2017
Pyrazolyl-ureas as kinase inhibitors
RESPIVERT LTD10 citations80
US9340545B2May 17, 2016
Quinazolin-4 (3H)—one derivatives used as P13 kinase inhibitors
RESPIVERT LTD1 citations62
US9321773B2Apr 26, 2016
Compounds
RESPIVERT LTD2 citations62
US10358445B2Jul 23, 2019
Respiratory formulations and compounds for use therein
RESPIVERT LTD1 citations61
US10028959B2Jul 24, 2018
Quinazolin-4 (3H)-one derivatives used as P13 kinase inhibitors
RESPIVERT LTD0 citations51
US10000471B2Jun 19, 2018
Pyrazole P38 map kinase inhibitors
RESPIVERT LTD0 citations51
US9834560B2Dec 5, 2017
Compounds
RESPIVERT LTD1 citations51
US9771354B2Sep 26, 2017
Pyrazole p38 map kinase inhibitors
RESPIVERT LTD1 citations51
US9637494B2May 2, 2017
Quinazolin-4 (3H)-one derivatives used as P13 kinase inhibitors
RESPIVERT LTD0 citations51
US10144721B2Dec 4, 2018
P38 MAP kinase inhibitors
RESPIVERT LTD0 citations50
PULMOCIDE LTD
12 patentsUS10106531B2Oct 23, 2018
Compound useful to treat mycoses
PULMOCIDE LTD10 citations92
US11661415B2May 30, 2023
Process for preparing a compound useful to treat mycoses
PULMOCIDE LTD2 citations84
US10858345B2Dec 8, 2020
Process for preparing a compound useful to treat mycoses
PULMOCIDE LTD3 citations84
US10662179B2May 26, 2020
Process for preparing a compound useful to treat mycoses
PULMOCIDE LTD3 citations84
US10450304B2Oct 22, 2019
Compound useful to treat mycoses
PULMOCIDE LTD4 citations84
US10344022B2Jul 9, 2019
Compound useful to treat mycoses
PULMOCIDE LTD7 citations84
US10035810B2Jul 31, 2018
5,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivative
PULMOCIDE LTD2 citations72
US10189863B2Jan 29, 2019
5,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivatives
PULMOCIDE LTD3 citations71
US12269814B2Apr 8, 2025
Process for preparing a compound useful to treat mycoses
PULMOCIDE LTD0 citations62
US10472375B2Nov 12, 2019
5,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivative
PULMOCIDE LTD0 citations50
US10273249B2Apr 30, 2019
5,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivative
PULMOCIDE LTD0 citations50
US10626126B2Apr 21, 2020
Compounds
PULMOCIDE LTD0 citations38
ITO KAZUHIRO
6 patentsUS8642773B2Feb 4, 2014
P38MAP kinase inhibitor
ITO KAZUHIRO44 citations97
US8618140B2Dec 31, 2013
P38 MAP kinase inhibitors
ITO KAZUHIRO41 citations97
US8299074B2Oct 30, 2012
P38 MAP kinase inhibitors
ITO KAZUHIRO48 citations97
US8299073B2Oct 30, 2012
P38 MAP kinase inhibitors
ITO KAZUHIRO50 citations97
US8293771B2Oct 23, 2012
p38 MAP kinase inhibitors
ITO KAZUHIRO49 citations97
US8293748B2Oct 23, 2012
p38 MAP kinase inhibitors
ITO KAZUHIRO47 citations97